Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
23
Number of overlapping holdings
16.9%
% of XBI's 136 holdings also in PBE
82.1%
% of PBE's 28 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus PBE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 3.5% | 5.1% | 3.5% |
|
GILEAD SCIENCES INC | 3.0% | 5.1% | 3.0% |
|
INCYTE CORP | 2.9% | 4.7% | 2.9% |
|
UNITED THERAPEUTICS CORP | 2.9% | 5.0% | 2.9% |
|
NEUROCRINE BIOSCIENCES INC | 2.8% | 2.8% | 2.8% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to PBE
|
ADVENTRX PHARMACEUTICALS INC | 2.8% |
|
INSMED INC | 2.6% |
|
VERTEX PHARMACEUTICALS INC | 2.6% |
|
ALNYLAM PHARMACEUTICALS INC | 2.5% |
|
ABBVIE INC | 2.4% |
|
MADRIGAL PHARMACEUTICALS, INC. | 2.2% |
|
VIKING THERAPEUTICS, INC. | 1.9% |
|
CYTOKINETICS INC | 1.6% |
|
MODERNA, INC. | 1.6% |
|
CRISPR THERAPEUTICS AG | 1.5% |
XBI Underweight Relative to PBE
|
ILLUMINA INC | -5.1% |
|
REGENERON PHARMACEUTICALS | -3.2% |
|
BIO-TECHNE CORPORATION | -2.8% |
|
BIOGEN IDEC INC | -2.7% |
|
COLLEGIUM PHARMACEUTICAL, INC. | -2.7% |
|
ROYALTY PHARMA PLC CLASS A | -2.6% |
|
AXSOME THERAPEUTICS, INC. | -2.6% |
|
AMGEN INC | -2.5% |
|
BIOCRYST PHARMACEUTICALS INC | -2.4% |
|
CATALYST PHARMACEUTICAL PART | -2.4% |